Results 101 to 110 of about 1,240,530 (301)
Mice previously infected with Schistosoma mansoni, and cured by specific treatment (400mg/kg oxamniquine, p. o.) in the chronic phase of the disease, were reinfected 20 days after treatment to assess their capacityfor modulation ofthe granulomatous ...
Paulo Marcos Z. Coelho+3 more
doaj +1 more source
Elevated MicroRNA-33 in Sarcoidosis and a Carbon Nanotube Model of Chronic Granulomatous Disease.
We established a murine model of multiwall carbon nanotube (MWCNT)-induced chronic granulomatous disease, which resembles human sarcoidosis pathology. At 60 days after oropharyngeal MWCNT instillation, bronchoalveolar lavage (BAL) cells from wild-type ...
B. Barna+9 more
semanticscholar +1 more source
Endomyocardial biopsy in the diagnosis of cardiac sarcoidosis
The diagnostic performance of endomyocardial biopsy (EMB) in 216 patients with cardiac sarcoidosis (CS). The overall sensitivity of the first EMB was 38%, although it varied markedly depending on the extent and severity of the disease. Major complications were rare (<1%) and no deaths or permanent sequels were observed.
Henriikka Mälkönen+5 more
wiley +1 more source
Granulomatosis with polyangiitis: Common and uncommon presentations
Summary Granulomatosis with polyangiitis (GPA) is a multisystemic autoimmune small vessel vasculitis predominantly affecting the respiratory and renal systems. Other systems such as the central nervous system, orbital, cardiac and gastrointestinal systems may also be involved to a lesser degree.
Qiao Xin Tee+3 more
wiley +1 more source
Common severe infections in chronic granulomatous disease.
BACKGROUND Chronic granulomatous disease (CGD) is due to defective nicotinamide adenine dinucleotide phosphate oxidase activity and characterized by recurrent infections with a limited spectrum of bacteria and fungi as well as inflammatory complications.
Beatriz E. Marciano+28 more
semanticscholar +1 more source
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons+17 more
wiley +1 more source
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor. Abstract Immune checkpoint inhibitors (ICIs) have successfully treated a number of different types of cancer, which is of great significance for cancer treatment.
Wenxian Wang+79 more
wiley +1 more source
This study investigated whether radiomic features extracted from radial‐probe endobronchial ultrasound (radial EBUS) images can assist in decision‐making for subsequent clinical management in cases with indeterminate pathologic results. We demonstrated a radiomics‐added, malignancy prediction model that can categorize lesions with nondiagnostic lung ...
Jihwan Choi+7 more
wiley +1 more source
Calculation of the mean duration and age of onset of a chronic disease and application to dementia in Germany [PDF]
This paper descibes a new method of calculating the mean duration and mean age of onset of a chronic disease from incidence and mortality rates. It is based on an ordinary differential equation resulting from a simple compartment model. Applicability of the method is demonstrated in data about dementia in Germany.
arxiv
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
A registry of United States residents with chronic granulomatous disease (CGD) was established in 1993 in order to estimate the minimum incidence of this uncommon primary immunodeficiency disease and characterize its epidemiologic and clinical features ...
J. Winkelstein+13 more
semanticscholar +1 more source